Literature DB >> 30725397

The Longitudinal Effects of Non-injection Substance Use on Sustained HIV Viral Load Undetectability Among MSM and Heterosexual Men in Brazil and Thailand: The Role of ART Adherence and Depressive Symptoms (HPTN 063).

Kiyomi Tsuyuki1, Steven J Shoptaw2, Yusuf Ransome3, Gordon Chau4, Carlos E Rodriguez-Diaz5, Ruth K Friedman6, Kriengkrai Srithanaviboonchai7,8, Sue Li4, Matthew J Mimiaga9, Kenneth H Mayer10, Steven A Safren11.   

Abstract

The effect of non-injection substance use on HIV viral load (VL) is understudied in international settings. Data are from HPTN063, a longitudinal observational study of HIV-infected individuals in Brazil, Thailand, and Zambia, with focus on men with VL data (Brazil = 146; Thailand = 159). Generalized linear mixed models (GLMM) assessed whether non-injection substance use (stimulants, cannabis, alcohol, polysubstance) was associated with VL undetectability. ART adherence and depressive symptoms were examined as mediators of the association. In Thailand, substance use was not significantly associated with VL undetectability or ART adherence, but alcohol misuse among MSM was associated with increased odds of depression (AOR = 2.75; 95% CI 1.20, 6.32, p = 0.02). In Brazil, alcohol misuse by MSM was associated with decreased odds of undetectable VL (AOR = 0.34; 95% CI 0.13, 0.92, p = 0.03). Polysubstance use by heterosexual men in Brazil was associated with decreased odds of ART adherence (AOR = 0.25; 95% CI 0.08, 0.78, p = 0.02). VL suppression appears attainable among non-injection substance users. Substance use interventions among HIV-positive men should address depression, adherence, and VL undetectability.

Entities:  

Keywords:  Adherence; Depression; HIV; Substance use; Undetectable viral load

Mesh:

Substances:

Year:  2019        PMID: 30725397      PMCID: PMC6414080          DOI: 10.1007/s10461-019-02415-w

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  50 in total

1.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Authors:  Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  Meta-analysis of the relationship between HIV infection and risk for depressive disorders.

Authors:  J A Ciesla; J E Roberts
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

3.  Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients.

Authors:  M P Nair; K C Chadha; R G Hewitt; S Mahajan; A Sweet; S A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

4.  Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Authors:  G M Lucas; L W Cheever; R E Chaisson; R D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2001-07-01       Impact factor: 3.731

5.  Methamphetamine-using HIV-positive men who have sex with men: correlates of polydrug use.

Authors:  Thomas L Patterson; Shirley J Semple; James K Zians; Steffanie A Strathdee
Journal:  J Urban Health       Date:  2005-02-28       Impact factor: 3.671

6.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

Authors:  E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro
Journal:  Arch Gen Psychiatry       Date:  2001-08

7.  Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment.

Authors:  L M Bogart; J A Kelly; S L Catz; J M Sosman
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-15       Impact factor: 3.731

8.  Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy.

Authors:  Ronald J Ellis; Meredith E Childers; Mariana Cherner; Deborah Lazzaretto; Scott Letendre; Igor Grant
Journal:  J Infect Dis       Date:  2003-12-08       Impact factor: 5.226

9.  Evidence implicating cocaine as a possible risk factor for HIV infection.

Authors:  Donald P Tashkin
Journal:  J Neuroimmunol       Date:  2004-02       Impact factor: 3.478

10.  Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men.

Authors:  C J Reback; S Larkins; S Shoptaw
Journal:  AIDS Care       Date:  2003-12
View more
  4 in total

Review 1.  HIV and Substance Use in Latin America: A Scoping Review.

Authors:  Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

2.  Prevalence and Risks of Depression and Substance Use Among Adults Living with HIV in the Asia-Pacific Region.

Authors:  Jeremy L Ross; Awachana Jiamsakul; Anchalee Avihingsanon; Man Po Lee; Rossana Ditangco; Jun Yong Choi; Reena Rajasuriar; Sivaporn Gatechompol; Iris Chan; Maria Isabel Echanis Melgar; Jung Ho Kim; Meng Li Chong; Annette H Sohn; Matthew Law
Journal:  AIDS Behav       Date:  2022-06-06

3.  Longitudinal Associations of Syndemic Conditions with Antiretroviral Therapy Adherence and HIV Viral Suppression Among HIV-Infected Patients in Primary Care.

Authors:  Satyanand Satyanarayana; Brooke G Rogers; Sierra A Bainter; Katerina A Christopoulos; Rob J Fredericksen; William C Mathews; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Adam W Carrico; Matthew J Mimiaga; Kenneth H Mayer; Heidi M Crane; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2021-06       Impact factor: 5.944

4.  Estimating HIV transmissions in a large U.S. clinic-based sample: effects of time and syndemic conditions.

Authors:  Satyanand Satyanarayana; Steven A Safren; Brooke G Rogers; Sierra A Bainter; Katerina A Christopoulos; Rob J Fredericksen; William C Mathews; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Adam W Carrico; Matthew J Mimiaga; Kenneth H Mayer; Heidi M Crane
Journal:  J Int AIDS Soc       Date:  2021-03       Impact factor: 5.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.